Home » Featured » Page 27
Featured
The results of a real-world Centers for Disease Control and Prevention (CDC) study of 1,843 health workers across the United States showed last week that COVID-19 mRNA vaccines authorized by the U.S. Food and Drug Administration (FDA) are 94 percent effective.
Currently approved mRNA vaccines... Read More »
In a public statement released last week, nine national organizations highlighted the pains COVID-19 inflicted upon the world in general and already historically marginalized populations in specific and pressed for strategies to improve crisis standards of care, along with equity.
“The... Read More »
Seven U.S. representatives introduced the State and Local Cybersecurity Improvement Act this week, which seeks to authorize a new Department of Homeland Security (DHS) grant program to fund local and state cybersecurity efforts.
In all, the program would benefit from $500 million in funding to... Read More »
Leaders of the House Energy and Commerce Committee and subcommittees wrote to Health and Human Services (HHS) Secretary Xavier Becerra this week urging a reversal of a Trump administration policy that stripped Food and Drug Administration (FDA) authority over COVID-19 lab-developed tests (LDTs).... Read More »
The U.S. Food and Drug Administration (FDA) announced Monday that the Pfizer-BioNTech vaccine is now authorized for emergency use among adolescents ages 12 through 15.
While children have seemingly been less susceptible to COVID-19 at large, they can still be carriers, and plenty have... Read More »
America’s historically underfunded public health system played a major role in the nation’s laggard COVID-19 response, according to a new report released by the Trust for America’s Health (TFAH).
And while it’s too soon to calculate with precision, it is likely that the United States... Read More »
The World Health Organization (WHO) added the Sinopharm COVID-19 vaccine produced by Beijing Bio-Institute of Biological Products Co Ltd. to the list of vaccines approved for emergency use worldwide last week, giving a potential new source and new boost for efforts by the COVAX... Read More »
Bloomberg Philanthropies will award up to $50,000 each to 18 cities in low and middle-income countries that are part of the Partnership for Healthy Cities and planning vaccine distribution rollouts with high-risk populations emphasized.
Vaccine preparedness activities, including communication... Read More »
Moderna, Inc. reported initial data this week showing that in phase two testing, its mRNA COVID-19 vaccine proved effective and well-tolerated as a booster or a single 50 µg dose on the previously vaccinated, against both the original SARS-CoV-2 strain and two variants of concern.
In all, three... Read More »
U.S. Sens. Mark Warner (D-VA) and Tim Kaine (D-VA), as well as Ben Cardin (D-MD) and Chris Van Hollen (D-MD), are urging President Joe Biden to resume the process of selecting a new home for the Federal Bureau of Investigation.
In a letter to the Biden administration, the four Congressmen... Read More »
President Joe Biden announced Tuesday a new federal goal to get at least one COVID-19 vaccine shot in 70 percent of the U.S. adult population and 160 million adults fully vaccinated by July 4, 2021.
Accessibility is the main focus in the next leg of the vaccination effort. To that end, the... Read More »
Responding to the spiraling COVID-19 situation in India, Pfizer Inc. announced this week that it will provide more than $70 million worth of medicines to the country immediately, with assistance from government and non-governmental organization partners.
“We are donating enough medicines to... Read More »
The global COVAX initiative received a major boost in its fight against COVID-19 this week through a new deal with Moderna, Inc. that will bring up to 500 million doses of vaccine into the fold for use by the lowest income countries, including up to 34 million doses this year alone.
Delivery of... Read More »
Recognizing the disproportionate impact of COVID-19 on certain communities, the National Institutes of Health (NIH) announced last week that it will fund an additional $29 million of grants for the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities.
Supported by the American... Read More »
When Ebola was a low priority for the private sector, the Department of Defense (DOD) was one of the few organizations that funded early-stage research and development on vaccines and treatments. The division of the DoD that played a critical role in that research was the Chemical and Biological... Read More »
A new report, the COVID CRIME INDEX 2021 REPORT, compiled by BAE Systems Applied Intelligence, found that cybercrime has experienced a massive uptick of 74 percent among banks and insurers alike since the COVID-19 pandemic began.
The data, which focused on financial institutions and their... Read More »
Merck has reached voluntary licensing agreements with five Indian generics manufacturers to produce molnupiravir for the COVID-stricken nation, granting it another oral therapeutic to aid the COVID-19 pandemic.
While molnupiravir is currently being studied in a phase three trial to treat... Read More »
As part of a new agreement reached with Moderna, Inc., Sanofi will provide fill/finish manufacturing services and supply packaging for up to 200 million doses of Moderna’s COVID-19 vaccine in the United States, beginning in September.
“We welcome the opportunity to work with Sanofi on... Read More »
After days of pressure on the U.S. government to respond with aid for the surging COVID-19 crisis in India, an arrangement is underway that will see the deployment of vaccines in the coming weeks, as well as health advisors, raw materials, personal protective equipment (PPE), and funding.... Read More »
Following a recommended pause due to rare cases of severe blood clots among those administered the Janssen (Johnson & Johnson) COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are encouraging use to continue.
The announcement followed... Read More »
U.S. Sens. Elizabeth Warren (D-MA) and Marco Rubio (R-FL) reintroduced last week the U.S. Pharmaceutical Supply Chain Review Act to demand a study of the nation’s reliance on foreign nations for the pharmaceutical supply chain.
The bill would require a study produced by the Federal Trade... Read More »
A bill introduced by U.S. Sens. Gary Peters (D-MI) and John Thune (R-SD) this week seeks to maintain the U.S. government’s edge in the modern world by establishing scholarships to encourage students enrolled in artificial intelligence programs to join the federal workforce.
Endorsed by the... Read More »
Responding to the rise in white supremacist and racist violence in the United States over the last few years, the Center for American Progress (CAP) and McCain Institute for International Learning have issued a joint, national strategy to curb the domestic threat.
“It’s time to get serious... Read More »
Several over-the-counter drugs could potentially find new lives treating COVID-19 symptoms, as the National Institutes of Health (NIH) announced this week that $155 million would be invested into a phase three trial of up to seven self-administered medications to that end.
It will be a... Read More »
The U.S. Food and Drug Administration (FDA) revoked last week the emergency use authorization (EUA) for the sole use of the monoclonal antibody therapy bamlanivimab against COVID-19.
“Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2... Read More »
Amid rising fears that variants of COVID-19 may already be reducing the efficacy of vaccines, INOVIO provided some good news last week, with news that its vaccine candidate produced neutralizing antibodies and T cell responses against all three major variant strains.
INO-4800, a DNA vaccine... Read More »
The U.S. Food and Drug Administration (FDA) released new guidance this week to clarify how it will request and conduct remote interactive evaluations during the ongoing COVID-19 pandemic, noting how critical such evaluations will be to operations.
This was meant for any FDA-regulated facilities,... Read More »
The University of Maryland, Baltimore County (UMBC) has utilized the BioFlash Biological Identifier created by Smiths Detection to successfully identify airborne traces of SARS-CoV-2 inside its campus in real-time.
BioFlash is a device that collects and analyses air samples, rapidly sifting... Read More »
A panel of public health experts and U.S. senators agreed on several steps Congress should take to prevent or remediate the next pandemic, basing their proposals on lessons learned during the 14 months working to resolve the COVID-19 health crisis.
Among their recommendations, aired during a... Read More »
FLIR Systems, Inc. announced Monday that it had won a contract with the Defense Advanced Research Projects Agency (DARPA) to develop new fabrics embedded with catalysts and chemical agents that can fight and reduce chemical and biological threats on contact.
The fabrics will be incorporated... Read More »
A mix of casirivimab and imdevimab, Regeneron Pharmaceuticals Inc.'s REGEN-COV, is now strongly recommended by the National Institutes of Health (NIH) for high risk COVID-19 patients that are non-hospitalized.
The drug was given a strong rate based on randomized trials, which involved more than... Read More »
The Centers for Disease Control and Prevention (CDC), the federal government’s nerve center for its COVID-19 pandemic response, would receive an additional $1.6 billion in funding over last year’s approved levels under President Joe Biden’s mammoth $1.5 trillion federal spending plan for... Read More »
The international COVAX facility has managed to deliver more than 38 million doses of various COVID-19 vaccine manufacturers to more than 100 economies within 42 days of its first international delivery to Ghana on Feb. 24, 2021.
It is a positive start for a massive global undertaking meant to... Read More »
An assessment by the COVID-19 subcommittee of the World Health Organization (WHO) Global Advisory Committee on Vaccine Safety (GACVS) has concluded that blood clots affiliated with the AstraZeneca vaccine are concerning but rare and require further study to determine a causal relationship.
All... Read More »
The Symbiotica COVID-19 Self-Collected Antibody Test System gained emergency use authorization from the United States Food and Drug Administration (FDA) this week, making it the first antibody test authorized for use with self-collected dried blood spot samples.
The test allows those prescribed... Read More »
